KLC2 and liver cancer: Overall, we characterized a complex epigenetic regulatory network, in which LINC00152 regulates the bioavailability of miR-143a-3p via its sponging function, thereby counteracting the tumor suppressive function of miR-143a-3p exerted by inhibition of KLC2 expression, which in turn promotes tumor growth of liver cancer cells.